Russia Industry Min Manturov: Russia auto market to contract 24% in 2015 even with govt measures
- Proposing spending an added RUB 25B to support the auto industry this year.
- Russia Dep Econ Min Vedev: expect rates will fall along with CPI
RTRS - GVC HOLDINGS PLC GVC.L CEO SAYS "BWIN IS AN INTERESTING COMPANY, SOMETHING LIKE BWIN WOULD BE OF INTEREST"
BWIN higher
Gapping down
In reaction to disappointing earnings/guidance: KSU -4.2%, FMSA -3.5%
Other news: MEIP -65.9% (announces top-line data from a randomized Phase II clinical study of Pracinostat in combination with azacitidine), IMMR -9.4% (announces settlement and license agreement With HTC Corporation (HTCKF) to resolve patent litigation), VRTX -7.1% (announces data from a 12-week Phase 2 study evaluating VX-661 in combination with ivacaftor in 39 people with CF ages 18 and older who have two copies of the F508del mutation), FINL -5.7% (unfavorable commentary on Friday's Mad Money), CERU -3.6% (appoints Chris Guiffre President and CEO), LULU -3% (still checking; worth noting several analysts out on name ahead of earnings this Thursday), GILD -2.4% (following reports of issues and a death related to its Harvoni Hep C drug taken in combination with amiodarone), SHPG -1.5% (may be down in symp with other bio/pharma names), GSK -1.4% (may be down in symp with other bio/pharma names), MNKD -1.1% (may be down in symp with other bio/pharma names), ARMH -1.1% (still checking), ABBV -0.7% (AbbVie (ABBV), which has a competing HCV drug Viekira with GILD), ACHN -0.5% (unfavorable commentary on Friday's Mad Money)
Analyst comments: NVDA -2.8% (downgraded to Sell from Neutral at Goldman), CCL -2.3% (downgraded to Hold at Deutsche Bank), OLN -1.8% (downgraded to Sell from Neutral at UBS), BIIB -1.8% (downgraded to Hold from Buy at Stifel), PRGO -1.6% (downgraded to Sector Perform at RBC Capital Mkts), NTAP -1.5% (downgraded to Neutral from Overweight at Piper Jaffray), EMC -1.1% (downgraded to Neutral from Overweight at Piper Jaffray)
In reaction to disappointing earnings/guidance: KSU -4.2%, FMSA -3.5%
Other news: MEIP -65.9% (announces top-line data from a randomized Phase II clinical study of Pracinostat in combination with azacitidine), IMMR -9.4% (announces settlement and license agreement With HTC Corporation (HTCKF) to resolve patent litigation), VRTX -7.1% (announces data from a 12-week Phase 2 study evaluating VX-661 in combination with ivacaftor in 39 people with CF ages 18 and older who have two copies of the F508del mutation), FINL -5.7% (unfavorable commentary on Friday's Mad Money), CERU -3.6% (appoints Chris Guiffre President and CEO), LULU -3% (still checking; worth noting several analysts out on name ahead of earnings this Thursday), GILD -2.4% (following reports of issues and a death related to its Harvoni Hep C drug taken in combination with amiodarone), SHPG -1.5% (may be down in symp with other bio/pharma names), GSK -1.4% (may be down in symp with other bio/pharma names), MNKD -1.1% (may be down in symp with other bio/pharma names), ARMH -1.1% (still checking), ABBV -0.7% (AbbVie (ABBV), which has a competing HCV drug Viekira with GILD), ACHN -0.5% (unfavorable commentary on Friday's Mad Money)
Analyst comments: NVDA -2.8% (downgraded to Sell from Neutral at Goldman), CCL -2.3% (downgraded to Hold at Deutsche Bank), OLN -1.8% (downgraded to Sell from Neutral at UBS), BIIB -1.8% (downgraded to Hold from Buy at Stifel), PRGO -1.6% (downgraded to Sector Perform at RBC Capital Mkts), NTAP -1.5% (downgraded to Neutral from Overweight at Piper Jaffray), EMC -1.1% (downgraded to Neutral from Overweight at Piper Jaffray)
Gapping up
In reaction to strong earnings/guidance: SVT +4.1%, BLRX +1.9%, DSKY +1.7%
M&A news: THC +4.8% (confirms that it and United Surgical Partners International will combine their ambulatory surgery and imaging centers in new JV; Tenet also announces purchase of Aspen Healthcare), SAN +1.5% (reports co plans to make bid for Novo Banco)
Other news: MCP +25% (60 Minutes reported on importance of rare earth elements), IMGN +22.4% (announces that Takeda (TKPYY) has licensed exclusive rights to use ImmunoGen's ADC technology to develop and commercialize targeted anticancer therapeutics to up to two undisclosed targets), FRSH +8.6% (favorable commentary on Friday's Mad Money), CANF +7.5% (signs multi-million dollar distribution agreement for CF101 in Canada with Cipher Pharmaceuticals (CPHR)), KMDA +6.1% (announces that the European Commission has designated its human intravenous Alpha-1 Antitrypsin as an orphan medicinal product to treat Graft-versus-host disease), NBG +4.5% (cont volatility surrounding Greece), CRNT +4.3% (announced that a Tier 1 mobile operator in Africa is investing approximately $4 million to expand its large scale Ceragon-based backbone network), BTN +4.2% (Issues statement in response to proxy contest), ESLT +1.3% (U.S. subsidiary awarded a $73.4 mln USMC IDIQ contract for Common Laser Range Finder), BLBD +1.1% (announces 92 Blue Bird propane-fueled school buses will power fleet of school vehicles in Colorado; also Hennessy Capital discloses 13.4% active stake in 13D filing), PAA +1.1% (Joint Venture with Delek Logistics to Build Caddo Pipeline)
Analyst comments: CAPN +9.9% (initiated with a Buy at Maxim Group), DVAX +5.9% (upgraded to Overweight from Neutral at JP Morgan; tgt raised to $36 from $15), GNW +5.7% (upgraded to Strong Buy from Outperform at Raymond James), NMM +5.3% (upgraded to Buy from Hold at Deutsche Bank), CYBR +3.6% (initiated with a Buy at BofA/Merrill), ITEK +3.5% (initiated with a Buy at Canaccord Genuity), SPLS +2.7% (upgraded to Buy from Neutral at UBS), AMH +1.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley), MSCC +0.9% (initiated with an Outperform at BMO Capital), TYC +0.8% (upgraded to Overweight at Barclays), AAPL +0.8% (target raised to $135 from $115 at Cowen)
In reaction to strong earnings/guidance: SVT +4.1%, BLRX +1.9%, DSKY +1.7%
M&A news: THC +4.8% (confirms that it and United Surgical Partners International will combine their ambulatory surgery and imaging centers in new JV; Tenet also announces purchase of Aspen Healthcare), SAN +1.5% (reports co plans to make bid for Novo Banco)
Other news: MCP +25% (60 Minutes reported on importance of rare earth elements), IMGN +22.4% (announces that Takeda (TKPYY) has licensed exclusive rights to use ImmunoGen's ADC technology to develop and commercialize targeted anticancer therapeutics to up to two undisclosed targets), FRSH +8.6% (favorable commentary on Friday's Mad Money), CANF +7.5% (signs multi-million dollar distribution agreement for CF101 in Canada with Cipher Pharmaceuticals (CPHR)), KMDA +6.1% (announces that the European Commission has designated its human intravenous Alpha-1 Antitrypsin as an orphan medicinal product to treat Graft-versus-host disease), NBG +4.5% (cont volatility surrounding Greece), CRNT +4.3% (announced that a Tier 1 mobile operator in Africa is investing approximately $4 million to expand its large scale Ceragon-based backbone network), BTN +4.2% (Issues statement in response to proxy contest), ESLT +1.3% (U.S. subsidiary awarded a $73.4 mln USMC IDIQ contract for Common Laser Range Finder), BLBD +1.1% (announces 92 Blue Bird propane-fueled school buses will power fleet of school vehicles in Colorado; also Hennessy Capital discloses 13.4% active stake in 13D filing), PAA +1.1% (Joint Venture with Delek Logistics to Build Caddo Pipeline)
Analyst comments: CAPN +9.9% (initiated with a Buy at Maxim Group), DVAX +5.9% (upgraded to Overweight from Neutral at JP Morgan; tgt raised to $36 from $15), GNW +5.7% (upgraded to Strong Buy from Outperform at Raymond James), NMM +5.3% (upgraded to Buy from Hold at Deutsche Bank), CYBR +3.6% (initiated with a Buy at BofA/Merrill), ITEK +3.5% (initiated with a Buy at Canaccord Genuity), SPLS +2.7% (upgraded to Buy from Neutral at UBS), AMH +1.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley), MSCC +0.9% (initiated with an Outperform at BMO Capital), TYC +0.8% (upgraded to Overweight at Barclays), AAPL +0.8% (target raised to $135 from $115 at Cowen)
RTRS - QATAR INVESTMENT AUTHORITY, DUFRY TEAMING UP TO BID FOR WORLD DUTY FREE -SOURCES
BFW 03/23 12:26 *PUBLICIS BOARD WILL CHOOSE A TEAM OF POTENTIAL CEO CANDIDATES
BN 03/23 12:26 *PUBLICIS BOARD WILL CHOOSE A TEAM OF POTENTIAL CEO CANDIDATES
BN 03/23 12:26 *PUBLICIS CEO SAYS TWO-TIERED BODY IS FORMING SUCCESSION PLAN
BN 03/23 12:26 *PUBLICIS CEO LEVY SPOKE AT ADWEEK IN LONDON
BN 03/23 12:26 *PUBLICIS BODY HAS MANAGEMENT AND NON-MANAGEMENT BOARD GROUPS
BN 03/23 12:26 *PUBLICIS BOARD WILL CHOOSE A TEAM OF POTENTIAL CEO CANDIDATES
BN 03/23 12:26 *PUBLICIS CEO SAYS TWO-TIERED BODY IS FORMING SUCCESSION PLAN
BN 03/23 12:26 *PUBLICIS CEO LEVY SPOKE AT ADWEEK IN LONDON
BN 03/23 12:26 *PUBLICIS BODY HAS MANAGEMENT AND NON-MANAGEMENT BOARD GROUPS
Publicis Board Mulls Team of Potential CEO Candidates, Levy Says
2015-03-23 12:39:37.6 GMT
By Amy Thomson
(Bloomberg) -- Publicis has two-tiered body formulating
succession plan, CEO Maurice Levy said to reporters at Adweek
event in London.
* Says body has mgmt, non-mgmt board members
* NOTE: French Ad Man Levy ‘Definite’ About Leaving Publicis
Job in 2017
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
To contact the reporter on this story:
Amy Thomson in London at +44-20-3525-0662 or
athomson6@bloomberg.net
To contact the editors responsible for this story:
James Ludden at +44-20-3525-2645 or
jludden@bloomberg.net
Kasper Viita, Mark Beech
2015-03-23 12:39:37.6 GMT
By Amy Thomson
(Bloomberg) -- Publicis has two-tiered body formulating
succession plan, CEO Maurice Levy said to reporters at Adweek
event in London.
* Says body has mgmt, non-mgmt board members
* NOTE: French Ad Man Levy ‘Definite’ About Leaving Publicis
Job in 2017
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
To contact the reporter on this story:
Amy Thomson in London at +44-20-3525-0662 or
athomson6@bloomberg.net
To contact the editors responsible for this story:
James Ludden at +44-20-3525-2645 or
jludden@bloomberg.net
Kasper Viita, Mark Beech
Early premarket gappers
Gapping up: MCP +8.3%, FSM +4.8%, SVT +4.1%, OXGN +3.2%, BLRX +1.9%, SPLS +1.4%, RDS.A+1.3%, BHP +1.3%, DB +1.2%, BLBD +1.1%, ESLT +1.1%, SAN +1%, ABX +0.9%
Gapping down: GILD -4.9%, CERU -3.6%, NBG -3%, IBN -2.3%, CCL -2.1%, SHPG -1.8%, MT -1.4%,BIIB -1.4%, GSK -1.3%, PRGO -1.3%, MNKD -1.1%, ARMH -1.1%
Gapping up: MCP +8.3%, FSM +4.8%, SVT +4.1%, OXGN +3.2%, BLRX +1.9%, SPLS +1.4%, RDS.A+1.3%, BHP +1.3%, DB +1.2%, BLBD +1.1%, ESLT +1.1%, SAN +1%, ABX +0.9%
Gapping down: GILD -4.9%, CERU -3.6%, NBG -3%, IBN -2.3%, CCL -2.1%, SHPG -1.8%, MT -1.4%,BIIB -1.4%, GSK -1.3%, PRGO -1.3%, MNKD -1.1%, ARMH -1.1%
+------------------------------------------------------------------------------+
BN 03/23 11:45 *VIVENDI: MOST SHAREHOLDERS MET ARE SATISFIED WITH STRATEGY BN 03/23 11:43 *VIVENDI SAYS TO EXAMINE REQUESTS ON DIVIDEND
+------------------------------------------------------------------------------+
Vivendi Says to Examine Requests on Dividend 2015-03-23 11:50:44.705 GMT
By Gaurav Panchal and Angeline Benoit (Bloomberg) -- Notes PSAM request to increase div. * Says return to shareholders is intended to amount to EU5.7b, which seems well balanced, keeping EU1 div. for 3 years and potential share buy-back of EU2.7b at max share price of EU20 * Says most shareholders met are satisfied with strategy * Management board opposes dismantling of company * Confirms it received a letter on Dec. 22 year from PSAM, asking for the sale of Universal Music Group. * Confirms it received a letter on Dec. 22 year from PSAM, asking for the sale of Universal Music Group.</li></ul> * Statment: Link * Earlier: Vivendi Says PSAM Fund Asked for Universal Music Spinoff Link
Link to Company News:{VIV FP <Equity> CN <GO>}
For Related News and Information: First Word scrolling panel: {FIRST<GO>} First Word newswire: {NH BFW<GO>}
To contact the editor responsible for this story: Gaurav Panchal at +44-20-3525-0511 or gpanchal2@bloomberg.net
Early premarket gappers
Gapping up: MCP +8.3%, FSM +4.8%, SVT +4.1%, OXGN +3.2%, BLRX +1.9%, SPLS +1.4%, RDS.A +1.3%, BHP +1.3%, DB +1.2%, BLBD +1.1%, ESLT +1.1%, SAN +1%, ABX +0.9%
Gapping down: GILD -4.9%, CERU -3.6%, NBG -3%, IBN -2.3%, CCL -2.1%, SHPG -1.8%, MT -1.4%, BIIB -1.4%, GSK -1.3%, PRGO -1.3%, MNKD -1.1%, ARMH -1.1%
RTRS - NORDEX NDXG.DE CEO SAYS OPEN TO BEING TAKEN OVER IF IT MAKES SENSE FROM AN OPERATIONAL POINT OF VIEW